All News

Brachytherapy alone, or in combination with external beam radiation therapy (EBRT), significantly reduces mortality rates in patients with high-risk prostate cancer, report the authors of a study from Thomas Jefferson University, Philadelphia.

The FDA has approved the oral kinase inhibitor axitinib (Inlyta) for the treatment of patients with advanced renal cell carcinoma after failure of one prior systemic therapy.

The 5-alpha-reductase inhibitor dutasteride (Avodart) appears to delay disease progression and the initiation of active treatment in men with low-risk, localized prostate cancer, results of a 3-year international clinical trial indicate.

A new meshless cystocele repair procedure intended to circumvent the problems seen with traditional repair appears to be durable and cost effective.

Results from a retrospective review reveal that microsurgical subinguinal varicocelectomy increases serum testosterone levels in men with clinically palpable varicoceles.

Managing the urethral strictures and fistulas that sometimes follow prostate cancer therapies can be intimidating, but with experience, the presentations can be resolved with high success in a near majority of patients.

Urologists think it's up to parents to decide whether circumcision should be performed on their child.

In this era of ever-increasing pressure to meet quality standards, it behooves us as a specialty to not only read but to follow our evidence-based guidelines.

Patrick Lowry, MD, discusses the scope of both obesity and stone disease, surgical and other challenges unique to managing stone disease in the obese, and steps obese adult and pediatric patients can take to lower their stone risk.

The rate of positive surgical margins after radical prostatectomy in men with either organ-confined or extracapsular disease varies significantly depending on preoperative PSA and pathologic Gleason sum score.

You probably know the financial bottom line of your practice, but how well do you understand just how you got there? To know, it's essential to periodically review your service mix.

New data from a single institution show that more patients with urothelial carcinoma are eligible for neoadjuvant chemotherapy before radical cystectomy than for adjuvant chemo following surgery.

As a result of a classic Washington decision just before Christmas, a 27.4% Medicare fee cut was delayed from its original Jan. 1 implementation date and is now scheduled, barring miraculous congressional action, to take effect on Feb. 29.

Pelvic floor muscle exercises (PFMEs) as a treatment for urinary incontinence after prostate surgery showed no significant difference in reduction of urinary leakage between intervention and control groups in a large multicenter study. Nevertheless, the randomized controlled trial still has a positive message about a role for pelvic floor muscle training considering that although men in the control group did not receive supervised training, some were also performing PFMEs and benefited with decreased urinary leakage.

I can't speak for everybody in every part of the country, but when I refused to sign contracts, my income doubled.

The current trends, if allowed to continue, will change the practice of medicine as we know it, even for employed physicians. In this article, we provide an overview of the current macroeconomics of health care, how they affect practicing urologists, and what steps you can take now to ensure you receive a fair share of the health care dollar.

Patients with severe testicular trauma typically face two treatment options: orchiectomy or orchidorrhaphy. A new analysis of national trauma reports suggests that race and insurance status, rather than geography, type of trauma, severity of injury, or other factors, play key roles in decisions that lead to excision or salvage of a damaged testis.

The newest urology products and services from Minimally Invasive Devices, Inc., Merck, GE Healthcare, Pacira Pharmaceuticals International, Iris Sample Processing, HealthForce1, Cardinal Health, and the American Urogynecologic Society.

Higher-volume centers tend to treat adrenalectomy patients who are younger, have a shorter length of stay, and are less likely to die in the hospital when compared to patients treated at lower-volume centers. Researchers found that very low-volume centers treat patients who are older, more likely to be female, and covered by Medicaid or uninsured.

If a patient is already having surgery that would allow for access to the bladder, surgical repair can be worthwhile.

A 4-year retrospective study suggests that re-resection for all T1 bladder tumors, with and without muscle in the original specimen, can provide important prognostic information to guide treatment.

Fatherhood comes with burdens and travails, but one of the unanticipated benefits may be a lower risk of cardiovascular disease and death.

Obesity should not preclude a patient from undergoing robot-assisted laparoscopic prostatectomy (RALP), but these men may require more time for the procedure.

Results of a retrospective study identify several factors associated with success in achieving pregnancy after intrauterine insemination (IUI), but normal sperm morphology is not among them.

A recent study suggests that a substantial portion of men with comorbidities serious enough to affect their lifespan are also being subjected to likely unnecessarily aggressive therapy.

There are many factors to be considered prior to implementing any type of charitable trust strategy.

Urologists around the country discuss the extent they turn to clinical guidelines or to their own experience when deciding their approach to patient care.

A developing advocacy campaign in Washington state has the AACU Government Affairs team implementing the very practices described in this space and thereby urged upon urologists in seemingly ad nauseum Calls to Action.